TrademarkDir
RUVIDAR
LIVE

Serial Number

98088134

Owner

Theralase Technologies Inc.

Attorney

David M. Tener, Esq.

Filing Date

Jul 17, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RUVIDAR Trademark

Serial Number: 98088134 • Registration: 8217862

RUVIDAR is a trademark filed by Theralase Technologies Inc. on July 17, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Theralase Technologies Inc. (9 trademarks)

41 Hollinger Road
Toronto, ON M4B 3G4 , CA

Entity Type: 03

Trademark Details

Filing Date

July 17, 2023

Registration Date

April 21, 2026

Published for Opposition

March 3, 2026

Goods & Services

Photosensitizing agents for photodynamic therapy, namely, light-activated compounds for killing tumor cells and other hyperproliferating cells; photosensitizing agents for photo-activated disinfection, namely, light-activated compounds for killing pathogens; light-activated disinfectant compositions for killing pathogens

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 18, 2026 ERSI
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 9, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 9, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 9, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 9, 2026 REAP
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 20, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 20, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 20, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 5, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 4, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 4, 2025 GNSL
SUSPENSION LETTER WRITTEN
Apr 4, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2025 CRFA
ASSIGNED TO LIE
Mar 28, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 12, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 31, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 31, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 31, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 3, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 3, 2024 GNSL
SUSPENSION LETTER WRITTEN
Apr 3, 2024 CNSL
ASSIGNED TO EXAMINER
Mar 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2023 NWOS
NEW APPLICATION ENTERED
Jul 20, 2023 NWAP

Related Trademarks

More from this Owner

HE-X

HE-X

HE-X

HE-X

THERALASE

THERALASE

HEALING THE WORLD, ONE PATIENT AT A TIME

HEALING THE WORLD, ONE PATIENT AT A TIME

DESTROYING CANCER AT THE SPEED OF LIGHT

DESTROYING CANCER AT THE SPEED OF LIGHT

DESTROYING CANCER AT THE SPEED OF LIGHT

DESTROYING CANCER AT THE SPEED OF LIGHT